跳至主要内容
临床试验/CTRI/2017/08/009270
CTRI/2017/08/009270已完成2 期

A prospective open Labeled randomized clinical trial on "Eri Gunmam"(Peptic Ulcer Disease )with evaluation of trial drug "Uppu Chenduram-II" "

S Neelavathi1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2017年7月25日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
The therapeutic efficacy of trial drug Uppu Chenduram II on Eri Gunmam

研究概览

简要总结

The study is prospective open Labeled randomized phase II clinical trial to evaluate the therapeutic efficacy of UPPU CHENDURAM II 130 mg bid with warm water for 30days  in 40 patients during the trial period of 12 months that will be conducted in Government Siddha Medical college and hospital Palayamkottai Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug UPPU CHENDURAM II on ERIGUNMAM The secondary outcome will be the evaluation of Siddha diagnostic parameters

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient with appropriate symptoms of upper abdominal pain nausea waterbrash headache flatulence excessive sweating loss of body weight lack of food intake Patient who are willing to sign consent form and undergo laboratory investigations.

排除标准

  • Pregnant and lactating women Haemetemesis Malena Pancreatitis Inflammatory bowel disease Hyertensive heart disease Chronic kidney disease.

结局指标

主要结局

The therapeutic efficacy of trial drug Uppu Chenduram II on Eri Gunmam

时间窗: 30 days

次要结局

  • Evaluation of Siddha diagnostic parameters(30 days)

研究者

发起方
S Neelavathi
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验